Mentor Contour Profile Gel Implants: Clinical Outcomes at 10 Years

Medical professionals have long sought reliable data on long-term outcomes of breast implants. While prior research has shown silicone gel implants to be generally safe, gaps remain in understanding 10-year complication rates. This uncertainty drives the need for large-scale clinical studies. Existing literature provides limited insight into revision surgery outcomes. No prior work had resolved the long-term safety of textured implants in various surgical contexts. The gap motivated this study to track complications over a decade. Researchers aimed to address unanswered questions about implant durability and patient satisfaction. This paper contributes by offering detailed per-subject and per-implant data.

The study aimed to evaluate the safety and effectiveness of Contour Profile Gel/MemoryShape breast implants over 10 years. Researchers focused on four surgical groups: primary augmentation, revision-augmentation, primary reconstruction, and revision-reconstruction. The motivation was to provide evidence-based insights for surgeons and patients. The authors wanted to assess complication rates and reoperation needs. They sought to understand how implant performance varies by procedure type. The study aimed to measure outcomes like capsular contracture and infection. Researchers also wanted to track explantation and replacement rates. This work addresses a need for long-term data on implant safety.

The study used a prospective, open-label design across multiple centers. Participants included 955 women aged 22 or older. Subjects were divided into four groups based on procedure type. Complications were tracked using the Baker classification system. Data collection spanned 10 years with regular follow-ups. Researchers assessed outcomes on both per-subject and per-implant bases. Key endpoints included capsular contracture, infection, and reoperation rates. The Kaplan-Meier method estimated cumulative incidence rates.

The 10-year capsular contracture rate was 3.6% in primary augmentation cases. Revision-augmentation had a higher rate of 15.5% for this complication. Infection rates remained low, at 0.7% for primary augmentation. Primary reconstruction showed a 14.3% capsular contracture rate. Explantation with or without replacement reached 9.2% in primary augmentation. Revision-reconstruction had the highest explantation rate at 49.0%. Reoperation rates varied, with 59.7% in revision-reconstruction cases. These findings suggest implant safety and effectiveness across surgical types.

The authors state that Contour Profile Gel/MemoryShape implants are safe and effective for 10 years. The study shows acceptable complication rates across four surgical groups. Capsular contracture rates suggest implant stability in most cases. Infection rates remain low, indicating good biocompatibility. The authors propose that these implants are suitable for both primary and revision procedures. They suggest that textured shells may reduce certain complications. The authors claim that these findings support continued use of the device. They emphasize the importance of patient age and surgical context.